Tilia Fiduciary Partners Inc. Acquires 203 Shares of McKesson Co. (NYSE:MCK)

Tilia Fiduciary Partners Inc. raised its stake in shares of McKesson Co. (NYSE:MCK) by 4.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,889 shares of the company’s stock after buying an additional 203 shares during the period. McKesson accounts for approximately 1.7% of Tilia Fiduciary Partners Inc.’s portfolio, making the stock its 21st biggest holding. Tilia Fiduciary Partners Inc.’s holdings in McKesson were worth $2,417,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. RFP Financial Group LLC boosted its position in McKesson by 9.8% during the second quarter. RFP Financial Group LLC now owns 191 shares of the company’s stock worth $112,000 after purchasing an additional 17 shares during the period. Modera Wealth Management LLC raised its holdings in McKesson by 2.2% in the 2nd quarter. Modera Wealth Management LLC now owns 804 shares of the company’s stock worth $470,000 after acquiring an additional 17 shares during the period. Larson Financial Group LLC boosted its holdings in McKesson by 1.6% during the second quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock valued at $639,000 after acquiring an additional 17 shares during the period. First Western Trust Bank grew its position in shares of McKesson by 2.0% in the first quarter. First Western Trust Bank now owns 913 shares of the company’s stock valued at $490,000 after purchasing an additional 18 shares during the last quarter. Finally, KCM Investment Advisors LLC boosted its stake in McKesson by 1.4% during the 1st quarter. KCM Investment Advisors LLC now owns 1,355 shares of the company’s stock valued at $727,000 after purchasing an additional 19 shares during the period. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Activity at McKesson

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the business’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the completion of the transaction, the chief executive officer now directly owns 78,586 shares of the company’s stock, valued at approximately $44,094,604.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.11% of the stock is owned by corporate insiders.

McKesson Stock Up 0.5 %

Shares of McKesson stock traded up $2.29 during trading on Wednesday, reaching $497.38. 127,450 shares of the company were exchanged, compared to its average volume of 806,115. The business has a 50-day moving average price of $535.98 and a 200-day moving average price of $553.73. The firm has a market capitalization of $64.63 billion, a price-to-earnings ratio of 22.12, a P/E/G ratio of 1.18 and a beta of 0.44. McKesson Co. has a twelve month low of $431.35 and a twelve month high of $637.51.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 EPS for the quarter, beating analysts’ consensus estimates of $7.21 by $0.67. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The company had revenue of $79.28 billion during the quarter, compared to analysts’ expectations of $82.53 billion. During the same period in the prior year, the business posted $7.27 EPS. McKesson’s revenue was up 6.4% on a year-over-year basis. On average, equities research analysts forecast that McKesson Co. will post 32.07 EPS for the current fiscal year.

McKesson Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd were issued a $0.71 dividend. This is a positive change from McKesson’s previous quarterly dividend of $0.62. The ex-dividend date was Friday, August 30th. This represents a $2.84 annualized dividend and a dividend yield of 0.57%. McKesson’s payout ratio is 12.69%.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Robert W. Baird restated a “neutral” rating and issued a $531.00 price target (down from $603.00) on shares of McKesson in a research report on Tuesday, September 24th. Baird R W downgraded shares of McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 24th. Mizuho raised their price target on McKesson from $540.00 to $570.00 and gave the company a “neutral” rating in a report on Thursday, August 8th. Leerink Partners cut their price target on McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a report on Monday. Finally, StockNews.com lowered shares of McKesson from a “buy” rating to a “hold” rating in a report on Friday, September 27th. Five equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $610.86.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.